cycloguanil has been researched along with atovaquone in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jomaa, H; Mitsch, A; Schlitzer, M; Wiesner, J; Wissner, P | 1 |
| Bertaux, L; Bogreau, H; Bouchiba, H; Garnotel, E; Kraemer, P; Parzy, D; Pradines, B; Rogier, C; Savini, H; Simon, F | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P | 1 |
| Ager, AL; Canfield, CJ; Jacobus, DP; Lewis, NJ; Milhous, WK; Rossan, RN; Sweeney, TR | 1 |
| Christopherson, RI; Rieckmann, KH; Seymour, KK; Yeo, AE | 1 |
| Gillotin, C; Mamet, JP; Veronese, L | 1 |
| Ashton, M; Bergqvist, Y; Björkman, A; Johansson, I; Lindegårdh, N; Nivelius, S; Thapar, MM | 1 |
| Alifrangis, M; Jelinek, T; Salanti, A; Schwöbel, B | 1 |
| Bienzle, U; Ehrhardt, S; Jelinek, T; Mockenhaupt, FP; Muehlen, M; Otchwemah, R; Schreiber, J | 1 |
| Björkman, A; Gil, JP; Thapar, MM | 1 |
| Kioy, D; Konsil, J; Manyando, C; Miller, GB; Mulenga, M; Na-Bangchang, K; Ruengweerayut, R | 1 |
| Jiang, S; McConkey, GA; McRobert, L; Stead, A | 1 |
| Kamau, EM; Nduati, EW | 1 |
| Chua, HH; Cobbold, SA; Creek, DJ; McConville, MJ; Nijagal, B; Ralph, SA | 1 |
| Dinter, D; Domijan, AM; Gajski, G; Garaj-Vrhovac, V | 1 |
| Barata, L; Boutbibe, K; Clain, J; Franetich, JF; Houzé, P; Mazier, D; Zanghi, G | 1 |
| Funakoshi, R; Furihata, K; Ito, K; Kudo, T; Kusuhara, H; Tomoda, Y | 1 |
| Andrews, KT; Antonova-Koch, Y; Burrows, JN; Chopra, P; Clarke, M; Fidock, DA; Fisher, GM; Hutt, OE; Jarvis, KE; Meister, S; Riches, AG; Ryan, JH; Skinner-Adams, TS; von Itzstein, M; Wilson, T; Winzeler, EA | 1 |
| Jang, IJ; Ji, SC; Lee, S; Yang, E | 1 |
5 trial(s) available for cycloguanil and atovaquone
| Article | Year |
|---|---|
Lack of a pharmacokinetic interaction between atovaquone and proguanil.
Topics: Adult; Antimalarials; Atovaquone; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Naphthoquinones; Proguanil; Sex Factors; Triazines | 1999 |
Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis.
Topics: Adult; Antimalarials; Atovaquone; Biological Availability; Dose-Response Relationship, Drug; Drug Combinations; Female; Genotype; Humans; In Vitro Techniques; Male; Middle Aged; Naphthoquinones; Phenotype; Proguanil; Time Factors; Triazines | 2002 |
The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
Topics: Adolescent; Adult; Antimalarials; Atovaquone; Drug Combinations; Female; Humans; Malaria, Falciparum; Naphthoquinones; Pregnancy; Proguanil; Thailand; Triazines; Zambia | 2005 |
Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers.
Topics: Adult; Area Under Curve; Atovaquone; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Drug Combinations; Esomeprazole; Humans; Male; Proguanil; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Tandem Mass Spectrometry; Triazines; Young Adult | 2019 |
Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole.
Topics: Atovaquone; Cross-Over Studies; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Humans; Proguanil; Reducing Agents | 2023 |
15 other study(ies) available for cycloguanil and atovaquone
| Article | Year |
|---|---|
Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives.
Topics: Animals; Antimalarials; Cinnamates; Combinatorial Chemistry Techniques; Inhibitory Concentration 50; Microbial Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2001 |
First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
Topics: Animals; Antimalarials; Atovaquone; Comoros; Drug Resistance; France; Genotype; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Travel; Treatment Failure | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites | 2015 |
PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
Topics: Administration, Oral; Animals; Antimalarials; Aotus trivirgatus; Atovaquone; Drug Synergism; Folic Acid Antagonists; Imides; Injections, Subcutaneous; Malaria, Falciparum; Mice; Naphthoquinones; Phenyl Ethers; Plasmodium falciparum; Proguanil; Sulfamethoxazole; Triazines | 1993 |
Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.
Topics: Animals; Antimalarials; Atovaquone; Drug Interactions; Folic Acid; Humans; Leucovorin; Naphthoquinones; Plasmodium falciparum; Proguanil; Purine Nucleotides; Pyrimethamine; Pyrimidine Nucleotides; Triazines | 1997 |
Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Atovaquone; Codon; Drug Resistance; Electron Transport Complex III; Genetic Markers; Humans; Malaria, Falciparum; Mutation; Naphthoquinones; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proguanil; Triazines | 2003 |
Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Topics: Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Folic Acid Antagonists; Ghana; Humans; Infant; Malaria, Falciparum; Male; Mutation; Naphthoquinones; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Proguanil; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Triazines | 2004 |
In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
Topics: Animals; Antimalarials; Atovaquone; Culture Media; Cytochrome b Group; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Naphthoquinones; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Recurrence; Triazines | 2005 |
Plasmodium falciparum: interaction of shikimate analogues with antimalarial drugs.
Topics: Animals; Antimalarials; Atovaquone; Drug Interactions; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Shikimic Acid; Triazines | 2005 |
Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.
Topics: Animals; Antimalarials; Atovaquone; Dapsone; Drug Synergism; Drug Therapy, Combination; Folic Acid Antagonists; Naphthoquinones; Plasmodium falciparum; Proguanil; Triazines | 2006 |
Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs.
Topics: Antimalarials; Artemisinins; Atovaquone; Chloroquine; Fosfomycin; Gas Chromatography-Mass Spectrometry; Hemoglobins; Inhibitory Concentration 50; Methylene Blue; Naphthyridines; Plasmodium falciparum; Proguanil; Triazines | 2016 |
Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro.
Topics: Adult; Antimalarials; Atovaquone; Cell Survival; Cytogenetics; DNA Damage; Dose-Response Relationship, Drug; Drug Combinations; Glutathione; Humans; Lymphocytes; Malaria, Falciparum; Male; Malondialdehyde; Oxidative Stress; Plasmodium falciparum; Proguanil; Triazines | 2015 |
In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites.
Topics: Antimalarials; Atovaquone; Drug Combinations; Hepatocytes; Humans; Inhibitory Concentration 50; Liver; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Triazines | 2016 |
Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Topics: Animals; Anopheles; Antimalarials; Atovaquone; Cyclization; Dihydroorotate Dehydrogenase; Dose-Response Relationship, Drug; Drug Combinations; Electron Transport Complex III; Enzyme Inhibitors; Erythrocytes; Folic Acid; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver; Oxidoreductases Acting on CH-CH Group Donors; Plasmodium berghei; Plasmodium falciparum; Proguanil; Sporozoites; Terpenes; Triazines | 2019 |